01.28.26 -- What Is Disease Progression Modeling, And When Is The Right Time To Use It?

At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.

Adaptable to any trial study, this team of experienced Certified Mobile Research Nurses travels directly to your trial participants, wherever they may be — at home, work, school, care centers, and more.

Pharma meetings run smoother when they reflect real site needs. This article breaks down how travel, timing, venue, and training choices strengthen engagement from the start. 

Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.

The CRO-sponsor partnership is strategic, addressing communication gaps and fragmented systems to improve efficiency.

By combining advanced automation, proprietary technologies, and deep regulatory knowledge, we provide efficient, high-quality ICSR services aligned with your operational needs and strategic goals.

Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.

As a full-service oncology CRO, our extensive oncology expertise, coupled with an end-to-end approach, helps accelerate your clinical oncology programs.

Because the skin is the largest and most easily accessible organ, our dermatology research also facilitates drug development in other areas, including immunology and endocrinology.